ePrints

Targeting leukemic fusion proteins with small interfering RNAs: recent advances and therapeutic potentials

Lookup NU author(s): Professor Olaf Heidenreich

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

RNA interference has become an indispensable research tool to study gene functions in a wide variety of organisms. Because of their high efficacy and specificity, RNA interference-based approaches may also translate into new therapeutic strategies to treat human diseases. In particular, oncogenes such as leukemic fusion proteins, which arise from chromosomal translocations, are promising targets for such gene silencing approaches, because they are exclusively expressed in precancerous and cancerous tissues, and because they are frequently indispensable for maintaining the malignant phenotype. This review summarizes recent developments in targeting leukemia-specific genes and discusses problems and approaches for possible clinical applications.

Publication metadata

Author(s): Thomas M, Greil J, Heidenreich O

Publication type: Article

Publication status: Published

Journal: Acta Pharmacologica Sinica

Year: 2006

Volume: 27

Issue: 3

Pages: 273-81

ISSN (print): 1671-4083

ISSN (electronic): 1745-7254

URL: http://dx.doi.org/10.1111/j.1745-7254.2006.00282.x

DOI: 10.1111/j.1745-7254.2006.00282.x

PubMed id: 16490161

Altmetrics

Share